Head-Off Tablet contains a combination of Naproxen 500 mg and Domperidone 10 mg, formulated to provide effective relief from pain and associated gastrointestinal discomfort. Naproxen is a nonsteroidal anti-inflammatory drug (NSAID) that exerts analgesic, anti-inflammatory, and antipyretic effects by inhibiting cyclooxygenase enzymes, thereby reducing the synthesis of prostaglandins responsible for pain and inflammation. Domperidone is a dopamine D2 receptor antagonist that enhances gastrointestinal motility and accelerates gastric emptying, which helps alleviate nausea and vomiting commonly associated with pain or NSAID therapy. Head-Off Tablet is indicated for the management of acute musculoskeletal pain, dysmenorrhea, dental pain, and other inflammatory conditions where pain relief is required alongside mitigation of gastrointestinal side effects. It should be used with caution in patients with a history of gastrointestinal ulcers, bleeding disorders, or cardiac conditions. The combination improves patient compliance by addressing both pain and nausea in a single dosage form. Administration should follow medical advice, and the tablet is contraindicated in individuals with hypersensitivity to Naproxen, Domperidone, or other NSAIDs. Common adverse effects may include gastrointestinal discomfort, dizziness, and dry mouth. Patients are advised to report any severe side effects or allergic reactions promptly.